2023 London Global Cancer Week

The Global Health Catalyst summit session during London Cancer Week will focus on the Cancer Moonshot 2.0: extending the cancer moonshot globally through win-win collaborations. When USA President Joe Biden and Dr. Jill Biden reignited the Cancer Moonshot (highlighted by the Lancet as Cancer Moonshot 2.0), they set ambitious, achievable goals: to reduce the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today. They called for everyone to do their part. While the immediate goals are domestic, the ambitions of the Cancer Moonshot extend far beyond the borders of the United States, especially as the burden of cancer falls heavily to lower- and middle-income countries (LMIC), where 80% of global cancer deaths occur. International work as part of the Cancer Moonshot is focused on equity and collaboration, thereby increasing access to prevention, screening, treatment, and care for everyone facing a cancer diagnosis and their families around the world. Following the Launch of the Lancet Oncology Commission for sub-Saharan Africaduring global health catalyst (GHC) summits with government leaders in different African countries, and in Europe and USA, the Cancer Moonshot Announced New Actions Aimed to Reduce the Cancer Burden in Africa as Part of the U.S.-Africa Leaders Summit in December 2022. During the London Cancer Week, the GHC will feature updates, highlight progress, and new opportunities for win-win collaborations with major impact for both the USA and collaborating country partners. Speakers will include leaders of the new Lancet Oncology Cancer Moonshot 2.0 commission, and other major stakeholders from government, industry, diaspora and non-profit organizations.